These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 33983474)

  • 1. Predicting Mycoplasma pneumoniae and Chlamydophila pneumoniae in community-acquired pneumonia (CAP) pneumonia: epidemiological study of respiratory tract infection using multiplex PCR assays.
    Ishimaru N; Suzuki S; Shimokawa T; Akashi Y; Takeuchi Y; Ueda A; Kinami S; Ohnishi H; Suzuki H; Tokuda Y; Maeno T
    Intern Emerg Med; 2021 Nov; 16(8):2129-2137. PubMed ID: 33983474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.
    Lui G; Ip M; Lee N; Rainer TH; Man SY; Cockram CS; Antonio GE; Ng MH; Chan MH; Chau SS; Mak P; Chan PK; Ahuja AT; Sung JJ; Hui DS
    Respirology; 2009 Nov; 14(8):1098-105. PubMed ID: 19818051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First report on prevalence and risk factors of severe atypical pneumonia in Vietnamese children aged 1-15 years.
    Huong Ple T; Hien PT; Lan NT; Binh TQ; Tuan DM; Anh DD
    BMC Public Health; 2014 Dec; 14():1304. PubMed ID: 25524126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A multicentre study on the pathogenic agents in 665 adult patients with community-acquired pneumonia in cities of China].
    Liu YN; Chen MJ; Zhao TM; Wang H; Wang R; Liu QF; Cai BQ; Cao B; Sun TY; Hu YJ; Xiu QY; Zhou X; Ding X; Yang L; Zhuo JS; Tang YC; Zhang KX; Liang DR; Lü XJ; Li SQ; Liu Y; Yu YS; Wei ZQ; Ying KJ; Zhao F; Chen P; Hou XN
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jan; 29(1):3-8. PubMed ID: 16638292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycoplasma pneumoniae and Chlamydophila pneumoniae in children with community-acquired pneumonia in Thailand.
    Lochindarat S; Suwanjutha S; Prapphal N; Chantarojanasiri T; Bunnag T; Deerojanawong J; Kunakorn M; Srisan P
    Int J Tuberc Lung Dis; 2007 Jul; 11(7):814-9. PubMed ID: 17609060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia.
    Zhou Y; Wang J; Chen W; Shen N; Tao Y; Zhao R; Luo L; Li B; Cao Q
    BMC Infect Dis; 2020 Aug; 20(1):633. PubMed ID: 32847534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pay attention to new evolution trends in the etiology of community-acquired pneumonia in adults].
    He LX
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jun; 47(6):576-581. PubMed ID: 38858211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of simple heuristics to target macrolide prescription in children with community-acquired pneumonia.
    Fischer JE; Steiner F; Zucol F; Berger C; Martignon L; Bossart W; Altwegg M; Nadal D
    Arch Pediatr Adolesc Med; 2002 Oct; 156(10):1005-8. PubMed ID: 12361446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of atypical pathogen: Mycoplasma pneumoniae and Chlamydia pneumoniae in the acute respiratory infection in childhood].
    Ouchi K
    Jpn J Antibiot; 2000 Jun; 53 Suppl B():13-21. PubMed ID: 12572086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etiological analysis and predictive diagnostic model building of community-acquired pneumonia in adult outpatients in Beijing, China.
    Liu YF; Gao Y; Chen MF; Cao B; Yang XH; Wei L
    BMC Infect Dis; 2013 Jul; 13():309. PubMed ID: 23834931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of respiratory bacterial pathogens causing atypical pneumonia by multiplex Lightmix
    Wagner K; Springer B; Imkamp F; Opota O; Greub G; Keller PM
    Int J Med Microbiol; 2018 Apr; 308(3):317-323. PubMed ID: 29397298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled non-inferiority trial of placebo versus macrolide antibiotics for Mycoplasma pneumoniae infection in children with community-acquired pneumonia: trial protocol for the MYTHIC Study.
    Meyer Sauteur PM; Seiler M; Tilen R; Osuna E; von Wantoch M; Sidorov S; Aebi C; Agyeman P; Barbey F; Bielicki JA; Coulon L; Deubzer B; Donas A; Heininger U; Keitel K; Köhler H; Kottanattu L; Lauener R; Niederer-Loher A; Posfay-Barbe KM; Tomaske M; Wagner N; Zimmermann P; Zucol F; von Felten S; Berger C
    Trials; 2024 Oct; 25(1):655. PubMed ID: 39363201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective.
    Gramegna A; Sotgiu G; Di Pasquale M; Radovanovic D; Terraneo S; Reyes LF; Vendrell E; Neves J; Menzella F; Blasi F; Aliberti S; Restrepo MI;
    BMC Infect Dis; 2018 Dec; 18(1):677. PubMed ID: 30563504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical pathogens as etiologic agents in hospitalized patients with community-acquired pneumonia in Korea: a prospective multi-center study.
    Sohn JW; Park SC; Choi YH; Woo HJ; Cho YK; Lee JS; Sim HS; Kim MJ
    J Korean Med Sci; 2006 Aug; 21(4):602-7. PubMed ID: 16891800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and Clinical Presentation of Mucocutaneous Disease Due to Mycoplasma pneumoniae Infection in Children With Community-Acquired Pneumonia.
    Meyer Sauteur PM; Theiler M; Buettcher M; Seiler M; Weibel L; Berger C
    JAMA Dermatol; 2020 Feb; 156(2):144-150. PubMed ID: 31851288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective surveillance for atypical pathogens in children with community-acquired pneumonia in Japan.
    Bamba M; Jozaki K; Sugaya N; Tamai S; Ishihara J; Kori T; Shiro H; Takeuchi Y; Cho H; Nakao A; Okano Y; Kimura K; Komiyama O; Nonoyama M; Kobayashi I; Kato T; Sunakawa K
    J Infect Chemother; 2006 Feb; 12(1):36-41. PubMed ID: 16506088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of priority pathogens for aetiological diagnosis in adults with community-acquired pneumonia in China: a multicentre prospective study.
    Zhang L; Xiao Y; Zhang G; Li H; Zhao J; Chen M; Chen F; Liu L; Li Y; Peng L; Zhao F; Yang D; Wen Z; Wu L; Wu S; Sun Y; Wang Y; Chen L; Wang X; Wang L; Li W; Qiu H; Chen Y; Gao Z; Ren L; Wang J
    BMC Infect Dis; 2023 Apr; 23(1):231. PubMed ID: 37059987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Atypical Pathogens in Patients With Cough and Community-Acquired Pneumonia: A Meta-Analysis.
    Marchello C; Dale AP; Thai TN; Han DS; Ebell MH
    Ann Fam Med; 2016 Nov; 14(6):552-566. PubMed ID: 28376442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in Children with Acute Respiratory Infections from Lima, Peru.
    Del Valle-Mendoza J; Orellana-Peralta F; Marcelo-Rodríguez A; Verne E; Esquivel-Vizcarra M; Silva-Caso W; Aguilar-Luis MA; Weilg P; Casabona-Oré V; Ugarte C; Del Valle LJ
    PLoS One; 2017; 12(1):e0170787. PubMed ID: 28129377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team.
    Mundy LM; Oldach D; Auwaerter PG; Gaydos CA; Moore RD; Bartlett JG; Quinn TC
    Chest; 1998 May; 113(5):1201-6. PubMed ID: 9596295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.